预测大核心梗死取栓后恶性大脑中动脉梗死的列线图
本研究回顾性分析2019年1月至2024年6月接受血管内治疗的大核心梗死急性缺血性卒中患者179例,45例(25.2%)发生恶性大脑中动脉梗死。基于房颤、NIHSS评分、血糖、CTP缺血核心体积和改良首过效应构建的列线图区分度良好(AUC=0.894,95%CI:0.843–0.944),校准曲线一致性高(Hosmer-Lemeshow检验p=0.842)。
要点
- 大核心梗死取栓后25.2%(45/179)发生恶性大脑中动脉梗死,列线图AUC=0.894可用于风险预测。
- CTP缺血核心体积(rCBF<30%)每增加1 mL,恶性梗死风险OR=1.027(95%CI:1.014–1.039)。
- 改良首过效应为保护因素(OR=0.325,95%CI:0.114–0.926),房颤患者风险升高(OR=3.551)。
核心结论
- NIHSS评分、房颤、血糖、CTP缺血核心体积和改良首过效应是大核心梗死取栓后恶性大脑中动脉梗死的独立预测因素,列线图预测性能良好(AUC=0.894,95%CI:0.843–0.944)。
研究设计与样本
- 回顾性分析2019年1月至2024年6月接受血管内治疗的大血管闭塞所致急性缺血性卒中大核心梗死患者179例,收集人口学、临床、影像和手术数据,采用前向消除法多变量逻辑回归筛选独立预测因素并构建列线图。
诊断标准与关键数值
- 列线图纳入房颤(OR=3.551,95%CI:1.381–9.127)、NIHSS评分每分(OR=1.130,95%CI:1.062–1.202)、血糖每mmol/L(OR=1.315,95%CI:1.116–1.550)、CTP缺血核心体积(rCBF<30%)每mL(OR=1.027,95%CI:1.014–1.039)和改良首过效应(OR=0.325,95%CI:0.114–0.926);AUC=0.894(95%CI:0.843–0.944),Hosmer-Lemeshow检验p=0.842。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Malignant middle cerebral artery infarction (mMCAi) is a life-threatening complication after large hemispheric infarction. This study aimed to develop a nomogram combining clinical and Computed Tomography Perfusion (CTP) parameters to predict the risk of mMCAi in patients with large core infarction following endovascular treatment (EVT). METHODS: We retrospectively analyzed patients with acute ischemic stroke due to large vessel occlusion (AIS-LVO) and large core infarction treated with EVT between January 2019 and June 2024. Demographic, clinical, imaging, and procedural data were collected. Multivariate logistic regression with forward elimination identified independent predictors of mMCAi. A nomogram was constructed based on these predictors, and its performance was assessed using the area under the receiver operating characteristic curve (AUC) and calibration analysis. RESULTS: Among 179 patients, 45 (25.2%) developed mMCAi after EVT. Atrial fibrillation (AF) (odds ratio [OR]=3.551, 95% confidence interval [CI]: 1.381–9.127), National Institutes of Health Stroke Scale (NIHSS) score (OR=1.130 per point, 95% CI: 1.062–1.202), serum glucose (OR=1.315 per mmol/L, 95% CI: 1.116–1.550), and ischemic core volume (relative Cerebral Blood Flow [rCBF] <30%, OR=1.027 per mL, 95% CI: 1.014–1.039) were independently associated with increased risk of mMCAi. modified First-Pass Effect (mFPE) was protective (OR=0.325, 95% CI: 0.114–0.926). The nomogram incorporating these variables showed excellent discrimination (AUC=0.894, 95% CI: 0.843–0.944), and the calibration curve showed a high concordance between predicted and actual risk (Hosmer-Lemeshow test p=0.842). CONCLUSIONS: Independent predictors of mMCAi included NIHSS score, AF, serum glucose level, ischemic core volume on CTP, and mFPE. The nomogram provides a practical and accurate tool for predicting mMCAi following EVT in patients with large core infarction.
引用
- Tang M, Ma Y, Liu Y, et al. A nomogram for predicting malignant middle cerebral artery infarction after thrombectomy in large core infarction. Neuroradiology. 2025. PMID: 41313450. doi:10.1007/s00234-025-03854-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。